Arthritis treatments - Wyeth Profit Climbs on Vaccine, Arthritis Treatments (Update6)
Jan. 30 (Bloomberg) -- Wyeth earnings climbed for a fifth straight quarter, rising 17 percent on demand for the arthritis drug Enbrel and the pneumonia vaccine Prevnar.
Last summer, I wrote a story about a new Chicago company that was making an eco-friendly soy-based chemical to extinguish a wide variety of fires, including jet fuel fires. It was a great idea.
Dont see your company on this list? The O-D Business Guide is posted at www.uticaOD.com and maintained online throughout the year. Please e-mail this information to infocenter@utica.gannett.com : * Company Name.
Genentech Inc. lost a ruling on a patent that generates an estimated $300 million a year in royalties from companies using the technology to make cancer and rheumatoid arthritis treatments.
CHICAGO -- Genentech Inc. lost a ruling on a patent that generates an estimated $300 million a year in royalties from rivals using the technology to make cancer and arthritis treatments.
Last summer, I wrote a story about a new Chicago company that was making an eco-friendly soy-based chemical to extinguish a wide variety of fires, including jet fuel fires. It was a great idea.
Dont see your company on this list? The O-D Business Guide is posted at www.uticaOD.com and maintained online throughout the year. Please e-mail this information to infocenter@utica.gannett.com : * Company Name.
Genentech Inc. lost a ruling on a patent that generates an estimated $300 million a year in royalties from companies using the technology to make cancer and rheumatoid arthritis treatments.
CHICAGO -- Genentech Inc. lost a ruling on a patent that generates an estimated $300 million a year in royalties from rivals using the technology to make cancer and arthritis treatments.
